Mendel Haag | Sr. Director
CSL Seqirus

Mendel Haag, Sr. Director, CSL Seqirus

Mendel Haag, PharmD, PhD is Senior Director and Head of the Center of Outcomes Research and Epidemiology at CSL Seqirus, where she leads global real-world evidence and epidemiology strategies to inform immunization policy, demonstrate vaccine value, and advance evidence-based public health. With more than 20 years of experience in epidemiology, outcomes research, and vaccine effectiveness evaluation, she has led numerous research collaborations and evidence-generation programs across the vaccine lifecycle. Prior to CSL Seqirus, Mendel held epidemiology leadership roles at Novartis and conducted research at Erasmus Medical Center in the Netherlands. She holds a PharmD from Utrecht University and an MSc and PhD in Clinical Epidemiology from Erasmus University.

Appearances:



Day 2 (21st October) @ 10:45

MF59-adjuvanted cell-derived higher-dose influenza vaccine: Building the Evidence for Influenza Prevention

last published: 18/Sep/26 14:06 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2026

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com


Stan Dooley

Stan.Dooley@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay up-to-date

Join our mailing list to receive exclusive content and offers.